NCT04938609: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
- State
- Under way
- Phase
- Phase 2
- People
- 28 taking part
- Started
- 11 Jan 2022
- Primary completion
- 11 Jan 2027
- Arms
- Pembrolizumab + SBRT + Surgery
- Results
- None posted
- 24 Jun 2021: Trial registered
- 11 Jan 2022: Trial started